Freeport-McMoRan Inc (NYSE:FCX) had its price target upped by analysts at Jefferies Group LLC to $16.00 in a report released on Tuesday.
Today, the stock opened at $33.97 and the last bid at the time of writing stood at $34.21.
Several research analysts have recently commented on FCX shares. Investors who are keeping close eye on the stock of Freeport-McMoRan Inc. BMO Capital Markets reiterated a "hold" rating and set a $15.00 target price on shares of Freeport-McMoRan in a research note on Thursday, December 29th. Finally, FBR & Co reiterated a "hold" rating on shares of Freeport-McMoRan in a research report on Tuesday, February 21st. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. They now have a Dollars 13 price target on the stock.
Freeport-McMoRan Inc. closed its last trading session at $12.23 with the gain of 7.11%. The stock was sold at an average price of $15.22, for a total transaction of $38,430.50.
Freeport has said it will only agree to a new permit with the same fiscal and legal protection in its current contract. Freeport has credit availability worth $3.5 billion at the end of the reported quarter. Freeport-McMoRan also saw some unusual options trading on Monday. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
Freeport-McMoRan Inc.'s P/E stands at *TBA, while the P/S is at 1.18 and earnings per share this year of 73.90%. The natural resource company reported $0.15 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.16 by $0.01.
8 number of analysts have estimated the sales of the company for the quarter ending April 25, 2017, analysts estimated mean sale target of 3851.87 million while high and low sale targets are estimated at 4283.1 million and 3361.87 million respectively. The Return on Equity ratio of Freeport-McMoRan Inc. Sales growth past 5 years was measured at -6.60%.
Freeport-McMoRan Inc (NYSE:FCX) have shown a low EPS growth of -21.20% in the last 5 years and has earnings growth of 106.50% yoy. The Q2 2017 consensus earnings estimates for the company have stabilized at US$0.24 per share.
TRADEMARK VIOLATION WARNING: This story was posted by BBNS and is owned by of BBNS. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and global copyright and trademark legislation. The original version of this piece can be accessed at https://transcriptdaily.com/2017/04/26/freeport-mcmoran-inc-fcx-downgraded-to-buy-at-vetr-inc.html.
The objective of a stock price analysis is to study the behaviour of stock prices. Ltd. now owns 364,824 shares of the natural resource company's stock valued at $3,962,000 after buying an additional 186,398 shares in the last quarter. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jon C/ Madonna sold 14,000 shares of the firm's stock in a transaction that occurred on Wednesday, February 1st. It worsened, as 61 investors sold FCX shares while 223 reduced holdings. The disclosure for this sale can be found here. Insiders sold a total of 151,645 shares of company stock valued at $2,340,571 over the last ninety days. Checchi Capital Advisers LLC boosted its stake in shares of Freeport-McMoRan by 30.2% in the third quarter. However, the uncertainty surrounding Freeport's Indonesian operations, which negatively impacted the company's copper shipments, remains to be resolved. Nikko Asset Management Americas Inc. boosted its position in Freeport-McMoRan by 8.0% in the first quarter.
Investors and Traders continue to monitor technical levels of shares of Corning Incorporated (GLW). The Firm operates through geographical assets with proven and probable reserves of copper, gold and molybdenum, and traded copper producer. The Company's segments include refined copper products, copper in concentrate, gold, molybdenum, oil and other.